<table id="table4" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 4: MEAN ± SD STEADY STATE SIROLIMUS PHARMACOKINETIC PARAMETERS IN LOW- TO MODERATE-IMMUNOLOGIC RISK ADULT RENAL TRANSPLANT PATIENTS FOLLOWING SIROLIMUS 2 MG DAILY<footnote>In presence of cyclosporine administered 4 hours before sirolimus dosing.</footnote>
<sup>,</sup>
<footnote>Based on data collected at months 1 and 3 post-transplantation.</footnote>
</caption>
<col align="left" valign="top" width="40%"></col>
<col align="center" valign="top" width="30%"></col>
<col align="center" valign="top" width="30%"></col>
<thead>
<tr>
<th></th>
<th colspan="2" valign="bottom">Multiple Dose (daily dose)</th>
</tr>
<tr>
<th></th>
<th valign="bottom">Solution</th>
<th valign="bottom">Tablets</th>
</tr>
</thead>
<tbody>
<tr>
<td>C<sub>max</sub> (ng/mL)</td>
<td>14.4 ± 5.3</td>
<td>15.0 ± 4.9</td>
</tr>
<tr>
<td>t<sub>max</sub> (hr)</td>
<td>2.1 ± 0.8</td>
<td>3.5 ± 2.4</td>
</tr>
<tr>
<td>AUC (ng∙h/mL)</td>
<td>194 ± 78</td>
<td>230 ± 67</td>
</tr>
<tr>
<td>C<sub>min</sub> (ng/mL)<footnote>Average C<sub>min</sub> over 6 months.</footnote>
</td>
<td>7.1 ± 3.5</td>
<td>7.6 ± 3.1</td>
</tr>
<tr>
<td>CL/F (mL/h/kg)</td>
<td>173 ± 50</td>
<td>139 ± 63</td>
</tr>
</tbody>
</table>